|Page (1) of 1 - 07/30/13||email article||print page|
This morning, Pfizer (PFE) reported lighter-than-expected revenue of $12.97 billion in the second quarter -- a 7% drop year-over-year. Excluding one-time items related to patent lawsuits and the sale of its remaining stake in Zoetis, the pharmaceutical company earned 56 cents per share, narrowly beating Wall Street estimates.
|Pfizer Tops Earnings Estimates, But Misses Revenue Numbers|
Source:GrabNetworks (c). All Rights Reserved